Patient Video - How has your KRAS mutation affected the treatment options available to you?
Terri discusses her treatment journey for her KRAS G12D-positive lung cancer. Currently there are no targeted treatments approved for the KRAS G12D lung cancer mutation, but knowing her mutation is important because it provides information on what treatment options are available to her for immunotherapy, surgery, or radiation. She is hopeful about the new treatments that are being researched in clinical trials.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Animation - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
Slide Show - Understanding NSCLC Treatment Options When You Have a KRAS Mutation
1.
What is a gene mutation and how does it relate to lung cancer?
2.
How do doctors test for genetic mutations in lung cancer and why is it important?
3.
What is a KRAS mutation in non-small cell lung cancer (NSCLC)?
4.
How do doctors treat lung cancer with KRAS mutations?
5.
How did you find out you had KRAS-positive lung cancer?
6.
What was the comprehensive biomarker testing experience like?
7.
What has your treatment experience been for your KRAS-positive lung cancer?
8.
What advice do you have for newly diagnosed lung cancer patients about biomarker testing?
9.
How did you find out you had KRAS-positive lung cancer?
10.
How has your KRAS mutation affected the treatment options available to you?
